CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,582.50
+9.80 (0.62%)
At close: Mar 25, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 96.79 billion as of March 26, 2026.
Market Cap
96.79B
Enterprise Value
96.87B
Revenue
13.44B
Ranking
n/a
PE Ratio
56.48
Stock Price
1,582.50
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 96.79B, an increase of 10.02%. That is a compound annual growth rate of 41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 96.79B | 14.27% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 334.36B |
| AstraZeneca Pharma India | 207.25B |
| Granules India | 150.80B |
| Jubilant Pharmova | 136.99B |
| Rubicon Research | 130.25B |
| Caplin Point Laboratories | 120.65B |
| Viyash Scientific | 82.49B |
| Procter & Gamble Health | 81.99B |